[Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5]. 1982

U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001809 Blood Viscosity The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA. Blood Viscosities,Viscosities, Blood,Viscosity, Blood
D006438 Hemodilution Reduction of blood viscosity usually by the addition of cell free solutions. Used clinically (1) in states of impaired microcirculation, (2) for replacement of intraoperative blood loss without homologous blood transfusion, and (3) in cardiopulmonary bypass and hypothermia. Hemodilutions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006895 Hydroxyethyl Starch Derivatives Starches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups. Hetastarch,Elohes,HAES-steril,Hemohes,Hespan,Hydroxyethyl Starch (130 KD-0.4 Substitution),Hydroxyethyl Starch 130-0.4,Hydroxyethylated Starches,Pentafraction,Pentaspan,Pentastarch,Plasmasteril,Starches, 2-Hydroxyethyl,2-Hydroxyethyl Starches,Derivatives, Hydroxyethyl Starch,Hydroxyethyl Starch 130 0.4,Starch Derivatives, Hydroxyethyl,Starches, 2 Hydroxyethyl,Starches, Hydroxyethylated
D001157 Arterial Occlusive Diseases Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency. Arterial Obstructive Diseases,Arterial Occlusion,Arterial Obstructive Disease,Arterial Occlusions,Arterial Occlusive Disease,Disease, Arterial Obstructive,Disease, Arterial Occlusive,Obstructive Disease, Arterial,Occlusion, Arterial,Occlusive Disease, Arterial
D013213 Starch Any of a group of polysaccharides of the general formula (C6-H10-O5)n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve (carbohydrates) in plants. Amylomaize Starch,Amylum,Cornstarch,Keoflo,Starch, Amylomaize

Related Publications

U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
April 1980, Infusionstherapie und klinische Ernahrung,
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
July 1993, Ugeskrift for laeger,
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
September 1989, Wiener medizinische Wochenschrift (1946),
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
January 1981, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
January 1977, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
January 1991, Acta medica Austriaca,
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
August 1986, Deutsche medizinische Wochenschrift (1946),
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
October 1986, Deutsche medizinische Wochenschrift (1946),
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
May 1992, Der Internist,
U Müller-Bühl, and H U Comberg, and C Diehm, and J Allenberg, and H Mörl
September 1983, The Journal of trauma,
Copied contents to your clipboard!